venBio Global Strategic GP, L.P., 10% Owner at Metacrine, Inc. (MTCR), sold 1,231,404 shares at $1.64 ($1.9M) on 2021-10-22, disclosed to the SEC on 2021-10-26.
Open-market sale of $1.9M MTCR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.64 | 75,035 | $123K | 6.6% |
| 2 | $1.64 | 75,035 | $123K | 6.6% |
| 3 | $1.49 | 540,667 | $806K | 43.4% |
| 4 | $1.49 | 540,667 | $806K | 43.4% |
| Total | $1.51 avg | 1,231,404 | $1.9M | 100% |